We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

104 hedge funds and large institutions have $147M invested in Sciclone Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 104 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less call options, than puts

Call options by funds: $707K | Put options by funds: $806K

Holders
104
Holders Change
+104
Holders Change %
–
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
104
Increased
–
Reduced
–
Closed
–
Calls
$707K
Puts
$806K
Net Calls
-$99K
Net Calls Change
-$99K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
51
First Trust Advisors
Illinois
$314K +$302K +63,375 New
Prudential Financial
52
Prudential Financial
New Jersey
$311K +$298K +62,637 New
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$281K +$270K +56,653 New
CS
54
Credit Suisse
Switzerland
$262K +$252K +52,872 New
Swiss National Bank
55
Swiss National Bank
Switzerland
$257K +$247K +51,900 New
NFA
56
Nationwide Fund Advisors
Ohio
$257K +$247K +51,913 New
ProShare Advisors
57
ProShare Advisors
Maryland
$235K +$225K +47,281 New
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$234K +$225K +47,217 New
GCP
59
GSA Capital Partners
United Kingdom
$227K +$218K +45,813 New
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$224K +$215K +45,250 New
RG
61
Renaissance Group
Kentucky
$208K +$200K +41,953 New
AIG
62
American International Group
New York
$194K +$186K +39,118 New
DC
63
Deere & Company
Illinois
$194K +$186K +39,035 New
SCM
64
Stevens Capital Management
Pennsylvania
$192K +$184K +38,696 New
PPA
65
Parametric Portfolio Associates
Washington
$184K +$177K +37,143 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$183K +$175K +36,860 New
VOYA Investment Management
67
VOYA Investment Management
Georgia
$183K +$176K +36,900 New
Public Employees Retirement Association of Colorado
68
Public Employees Retirement Association of Colorado
Colorado
$176K +$169K +35,567 New
Nomura Holdings
69
Nomura Holdings
Japan
$159K +$153K +32,225 New
Invesco
70
Invesco
Georgia
$144K +$138K +29,103 New
Principal Financial Group
71
Principal Financial Group
Iowa
$135K +$130K +27,253 New
UBS AM
72
UBS AM
Illinois
$130K +$125K +26,197 New
Tudor Investment Corp
73
Tudor Investment Corp
Connecticut
$128K +$123K +25,800 New
GMIM
74
General Motors Investment Management
New York
$115K +$111K +23,252 New
U
75
UBS
Switzerland
$114K +$110K +23,028 New
1 2
3
4 5

SCLN Hedge Fund Activity: Q2 2013 in Review

104 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2013, worth a combined $147M.

Buyers outnumbered sellers: 104 funds opened new SCLN positions and 0 closed out — a net gain of 104 holders — while 0 added to existing stakes and 0 trimmed.

  • 104 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $147M of Sciclone Pharmaceuticals Inc stock for Q2 2013.
  • 104 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +104 holders.

Based on aggregated 13F filings for Q2 2013.